Delivery Order SPE2DB22D2206-SPE2DB24FGS65
Award Date
4/17/24
Potential Completion Date
4/18/24
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,526.71 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of FYCOMPA 6 MG TABLET 30S, a prescription medication. The order has an ultimate completion date of August 12, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a range of pharmaceutical and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,270.09, is for the delivery of FYCOMPA 0.5 MG/ML oral suspension (340 mL) to support federal healthcare programs, particularly military treatment facilities and veterans' healthcare. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of March 4, 2025. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,528.87 firm fixed-price delivery order covers the supply of FYCOMPA 0.5 MG/ML oral suspension medical products. The contract has a completion date of June 4, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,786.49 firm fixed-price delivery order is for the supply of FYCOMPA 0.5 MG/ML oral suspension, a prescription medication, with a completion date of June 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds significant...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,924.48. It does not have a set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a $1,235.33 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The delivery order is for the supply of FYCOMPA 4 MG TABLET 30S, a prescription medication, with a period of performance through August 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award, valued at $3,848.96, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the corporate office of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a prescription medication, to the DLA. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. The contract is a Delivery Order with a Firm Fixed Price of $2,903.46 and an Ultimate Completion Date of January 29, 2025. The contract is not designated as a Set-Aside. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a prescription medication, with a ceiling value of $2,201.60 and a performance period through April 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,261.18 for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...